Vol 6, No 1 (February 23, 2017) - Chinese Clinical Oncology

Editorial

Pancreaticoduodenectomy for pancreatic cancer: perspective from the United States

Aslam Ejaz, Jin He

PDF Pages: 1 Full Text (5354) Open Access

Improving clinical outcomes with pembrolizumab in patients with advanced melanoma

Dae Won Kim, Jonathan S. Zager, Zeynep Eroglu

PDF Pages: 2 Full Text (4800) Open Access

PARP inhibitor and platinum agent in triple negative breast cancer: utilizing innovative trial design to bring together something “new” and something “old”

Priyanka Sharma

PDF Pages: 3 Full Text (4596) Open Access

An ICGC major achievement in breast cancer: a comprehensive catalog of mutations and mutational signatures

François Bertucci, Max Chaffanet, Daniel Birnbaum

PDF Pages: 4 Full Text (5039) Open Access

Beginnings of a “gene cloud” definition in hepatocellular carcinoma

Christopher Taylor Barry

PDF Pages: 5 Full Text (2535) Open Access

Original Article

Comparison of short-term outcomes between laparoscopic-assisted and open complete mesocolic excision (CME) for the treatment of transverse colon cancer

Yong Wang, Chuan Zhang, Yi-Fei Feng, Zan Fu, Yue-Ming Sun

PDF Pages: 6 Full Text (5855) Open Access

Review Article

Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)

Priya Rastogi, D. Lawrence Wickerham, Charles E. Geyer Jr, Eleftherios P. Mamounas, Thomas B. Julian, Norman Wolmark

PDF Pages: 7 Full Text (8087) Open Access

The prospective of laparoscopic pancreaticoduodenectomy for cancer management

Hendi Maher, Weiwei Jin, Yiping Mou, Henry Davies

PDF Pages: 8 Full Text (6369) Open Access

Commentary

The promise of using histone deacetylase inhibitors in combination treatment against breast cancer and other solid tumors

Nirmal Perera, Alexander Hergovich

PDF Pages: 9 Full Text (5045) Open Access

Commentary on “LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress”

Sara Malih, Massoud Saidijam

PDF Pages: 10 Full Text (3149) Open Access

Your View

Future prospect of gallbladder therapy using Hedgehog signaling inhibitor

Hideya Onishi

PDF Pages: 11 Full Text (2507) Open Access

Chromodomain-helicase-DNA-binding protein 4: a novel therapeutic target in liver cancer stem cells

Kouki Nio, Taro Yamashita, Shuichi Kaneko

PDF Pages: 12 Full Text (3386) Open Access

Meet the Professor¹

Professor Norman Wolmark: perseverance sometimes pays off

Chao-Xiu (Melanie) He

PDF Pages: 13 Full Text (Video) (2030) Open Access

Disclosure:

1. The series “Meet the Professor” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding.

Vol 6, No 1 (February 23, 2017): Chinese Clinical Oncology